Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer × avelumab × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 8 Carcinoma, Transitional Cell 8 Carcinoma, Renal Cell 5 Carcinoma, Merkel Cell 5 Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Turcot syndrome 1 Thymoma 1 Sarcoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Osteosarcoma 1 Motor Activity 1 Microsatellite Instability 1 Metastatic Urothelial Cancer 1

Interventions

olaparib 2 Pluvicto 2 testosterone 17 beta-cypionate 1 sarilumab 1 radium Ra 223 dichloride 1 lactitol 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 enfortumab vedotin 1 darolutamide 1 cemiplimab 1 Radium-223 1 Prednisone 1 Prednisolone 1 PSMA-617 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Cyclophosphamide 1 Blood Specimen Collection 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡